Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

MRI-derived myocardial extracellular volume fraction (ECV) is elevated in the presence of fibrosis, amyloid deposition, inflammation and edema. In patients with cardiac amyloidosis and prolonged T2 ...

and the lungs for crackles, which may indicate heart failure. Electrophysiological changes in myocardial function commonly occur in patients with heart failure secondary to amyloidosis.

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

McDade said this study has the longest-running data for any patients who started amyloid-lowering biologics while they were still free of symptoms. “We think that there’s a delay in the ...

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons—as a therapeutic target for Alzheimer's disease. But anti-amyloid ...

But an infection can also lead to other issues, including lung and heart damage and microbiome changes in the gut, that may not always be recognized as long Covid but can still have a lasting ...

Faye Brennan is a content strategist & consultant, editor, writer, digital creator, and entrepreneur. She’s been ...